Cancer Stem-Like Properties in Colorectal Cancer Cells with Low Proteasome Activity One of the main reasons for cancer treatment resistance is the existence of cancer stem-like cells (CSCs). The authors elucidated the relationship between low proteasome activity cells and CSCs. [Clin Cancer Res] Abstract The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene Silencing Investigators found that glioblastoma stem cells lack LIN28 and express both let-7 and their target genes, suggesting LIN28-independent protection from let-7 silencing. [Cell Rep] Full Article | Graphical Abstract The Marrow Niche Controls the Cancer Stem Cell Phenotype of Disseminated Prostate Cancer Researchers showed that disseminated tumor cells (DTCs) recovered from marrow were significantly enriched for a cancer stem cells (CSCs) phenotype. Critically, the conversion of DTCs to CSCs is regulated by niche-derived GAS6 through the Mer/mTOR; molecules previously shown to regulate dormancy. [Oncotarget] Full Article Hepatocellular Carcinoma: Thyroid Hormone Promotes Tumorigenicity through Inducing Cancer Stem-Like Cell Self-Renewal Investigators report that thyroid hormone (TH) promotes cell self-renewal in hepatocellular carcinoma (HCC) cells. TH also increases the percentage of CD90+ HCC cells and promotes drug resistance of HCC cells. [Sci Rep] Full Article CD44 Variant-Dependent Redox Status Regulation in Liver Fluke-Associated Cholangiocarcinoma: A Target for CCA Treatment Researchers examined cystine-glutamate transporter-targeted CD44 variant isoforms (CD44v)-cancer stem cell therapy using sulfasalazine. Glutathione decreased and ROS increased after the treatment, leading to inhibition of cell proliferation and induction of cell death. Thus, the accumulation of CD44v leads to the suppression of p38MAPK in transforming bile duct cells. [Cancer Sci] Abstract Tyrosine Kinase Inhibitor SU11274 Increased Tumorigenicity and Enriched for Melanoma-Initiating Cells by Bioenergetic Modulation The authors showed that SU11274 enriched for melanoma-initiating cells in vivo. SU11274 substantially decreased number of cells in adherent and spheroid cultures, but increased their tumorigenic potential as determined by higher frequency of tumor-initiating cells in vivo. [BMC Cancer] Full Article Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype Researchers characterized the phenotype of tumor cells in the periphery focusing on tumor stemness, proliferation and chemo-resistance. This was investigated in situ in patient glioma tissue as well as in orthotopic glioblastoma xenografts. [PLoS One] Full Article Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells Scientists found that cancer stem cells had significantly lower oxygen consumption rate and extracellular acidification rate than non-stem cancer cells. Meanwhile, this subpopulation of cells consumed less glucose, produced less lactate and maintained lower ATP levels. [PLoS One] Full Article Targeted Inhibition of Dominant PI3-kinase Catalytic Isoforms Increase Expression of Stem Cell Genes in Glioblastoma Cancer Stem Cell Models Researchers examined the effect of isoform specific PI3K inhibitors in two models of glioblastoma (GBM) ancer stem cells, an established GBM stem cell line 08/04 and a neurosphere formation model. They identified the dominant catalytic PI3K isoform for each model, and inhibition of the dominant isoform blocked AKT phosphorylation, as did pan-PI3K/mTOR inhibition. [Int J Oncol] Abstract |